Ascidian Therapeutics
Ting-Wen Cheng has a diverse work experience in the field of scientific research. They are currently working as a Research Fellow at Ascidian Therapeutics since 2023. Prior to this, they held various roles at Pfizer, starting as a Senior Scientist in October 2015 and progressing to become a Principal Scientist in April 2019. They then served as a Senior Principal Scientist from October 2021 until June 2023. Before joining Pfizer, Ting-Wen Cheng worked as a Postdoctoral Fellow, first at the University of California, Davis from 2009 to 2011, and then at Pfizer from 2011 to 2015.
Ting-Wen Cheng obtained a Doctor of Philosophy (Ph.D.) degree in Cell and Developmental Biology from the University of California, Davis.
Ascidian Therapeutics
2 followers
Gene therapy is entering a new era as the field moves forward. But current technologies cannot overcome the challenges of many diseases. Ascidian’s unique approach aims to unlock these doors and enable treatment for millions of patients worldwide.